We are analyzing https://link.springer.com/article/10.1007/s003810050542.

Title:
Chemotherapy for brain stem gliomas | Child's Nervous System
Description:
Approximately 80% of tumors arising in the brain stem are diffuse intrinsic lesions. Patients typically present with a short duration of symptoms and signs with significant neurological impairment. Imaging findings are typical, and biopsy is not usually necessary to make a diagnosis. Standard treatment consists of radiotherapy alone. Although the majority of patients will show a significant improvement in neurological status following such treatment, the prognosis is very poor. The median time to disease progression is of the order of 5–6 months, the median survival time less than 1 year, and survival at 2 years and beyond, less than 10%. Over the last 10–15 years, numerous studies have been undertaken in an attempt to develop more effective treatment for children with diffuse intrinsic brain stem tumors. Using a hyperfractionated (twice-daily) schedule, doses of radiotherapy as high as 78 Gy have been given without success. Other approaches use chemotherapy combined with radiotherapy in a variety of different ways, including up-front, concurrent, and adjuvant chemotherapy, and high-dose chemotherapy with rescue. The results of these studies using chemotherapy, as well as other approaches using other systemic agents, are reviewed in detail.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Education
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,643,078 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

chemotherapy, article, stem, brain, tumors, privacy, cookies, content, information, publish, search, treatment, access, chapter, cancer, data, log, journal, research, childs, freeman, perilongo, radiotherapy, brainstem, discover, springer, make, optional, personal, including, parties, policy, find, track, nervous, system, gliomas, state, cite, georgio, explore, diffuse, intrinsic, patients, significant, neurological, median, time, survival, years,

Topics {✒️}

brain stem gliomas h3g 1a4 e-mail month download article/chapter brain stem privacy choices/manage cookies diffuse intrinsic lesions high-dose chemotherapy nervous system aims standard treatment consists full article pdf european economic area scope submit manuscript related subjects conditions privacy policy accepting optional cookies patients typically present significant neurological impairment tumors arising main content log journal finder publish median survival time check access instant access chemotherapy combined adjuvant chemotherapy article freeman information effective treatment privacy policy personal data article child' books a freeman department optional cookies manage preferences median time article log brainstem data protection essential cookies cookies skip subscription content similar content significant improvement neurological status institution subscribe article cite journal publish chemotherapy usage analysis

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Chemotherapy for brain stem gliomas
         description:Approximately 80% of tumors arising in the brain stem are diffuse intrinsic lesions. Patients typically present with a short duration of symptoms and signs with significant neurological impairment. Imaging findings are typical, and biopsy is not usually necessary to make a diagnosis. Standard treatment consists of radiotherapy alone. Although the majority of patients will show a significant improvement in neurological status following such treatment, the prognosis is very poor. The median time to disease progression is of the order of 5–6 months, the median survival time less than 1 year, and survival at 2 years and beyond, less than 10%. Over the last 10–15 years, numerous studies have been undertaken in an attempt to develop more effective treatment for children with diffuse intrinsic brain stem tumors. Using a hyperfractionated (twice-daily) schedule, doses of radiotherapy as high as 78 Gy have been given without success. Other approaches use chemotherapy combined with radiotherapy in a variety of different ways, including up-front, concurrent, and adjuvant chemotherapy, and high-dose chemotherapy with rescue. The results of these studies using chemotherapy, as well as other approaches using other systemic agents, are reviewed in detail.
         datePublished:
         dateModified:
         pageStart:545
         pageEnd:553
         sameAs:https://doi.org/10.1007/s003810050542
         keywords:
            Key words Brain stem tumors
            Treatment
            Chemotherapy
            Neurosurgery
            Neurosciences
         image:
         isPartOf:
            name:Child's Nervous System
            issn:
               1433-0350
               0256-7040
            volumeNumber:15
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:C. R. Freeman
               affiliation:
                     name:Departments of Oncology and Pediatrics, McGill University, 1650 Cedar Avenue, Room D5-400, Montreal, Quebec, Canada, H3G 1A4 e-mail: [email protected] Tel.: +1-514-934-8040 Fax: +1-514-934-8220
                     address:
                        name:Departments of Oncology and Pediatrics, McGill University, 1650 Cedar Avenue, Room D5-400, Montreal, Quebec, Canada, H3G 1A4 e-mail: [email protected] Tel.: +1-514-934-8040 Fax: +1-514-934-8220, , CA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Georgio Perilongo
               affiliation:
                     name:Department of Pediatrics, University of Padova, Via Giustiniani 3, I-35128 Padova, Italy
                     address:
                        name:Department of Pediatrics, University of Padova, Via Giustiniani 3, I-35128 Padova, Italy, , IT
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Chemotherapy for brain stem gliomas
      description:Approximately 80% of tumors arising in the brain stem are diffuse intrinsic lesions. Patients typically present with a short duration of symptoms and signs with significant neurological impairment. Imaging findings are typical, and biopsy is not usually necessary to make a diagnosis. Standard treatment consists of radiotherapy alone. Although the majority of patients will show a significant improvement in neurological status following such treatment, the prognosis is very poor. The median time to disease progression is of the order of 5–6 months, the median survival time less than 1 year, and survival at 2 years and beyond, less than 10%. Over the last 10–15 years, numerous studies have been undertaken in an attempt to develop more effective treatment for children with diffuse intrinsic brain stem tumors. Using a hyperfractionated (twice-daily) schedule, doses of radiotherapy as high as 78 Gy have been given without success. Other approaches use chemotherapy combined with radiotherapy in a variety of different ways, including up-front, concurrent, and adjuvant chemotherapy, and high-dose chemotherapy with rescue. The results of these studies using chemotherapy, as well as other approaches using other systemic agents, are reviewed in detail.
      datePublished:
      dateModified:
      pageStart:545
      pageEnd:553
      sameAs:https://doi.org/10.1007/s003810050542
      keywords:
         Key words Brain stem tumors
         Treatment
         Chemotherapy
         Neurosurgery
         Neurosciences
      image:
      isPartOf:
         name:Child's Nervous System
         issn:
            1433-0350
            0256-7040
         volumeNumber:15
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:C. R. Freeman
            affiliation:
                  name:Departments of Oncology and Pediatrics, McGill University, 1650 Cedar Avenue, Room D5-400, Montreal, Quebec, Canada, H3G 1A4 e-mail: [email protected] Tel.: +1-514-934-8040 Fax: +1-514-934-8220
                  address:
                     name:Departments of Oncology and Pediatrics, McGill University, 1650 Cedar Avenue, Room D5-400, Montreal, Quebec, Canada, H3G 1A4 e-mail: [email protected] Tel.: +1-514-934-8040 Fax: +1-514-934-8220, , CA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Georgio Perilongo
            affiliation:
                  name:Department of Pediatrics, University of Padova, Via Giustiniani 3, I-35128 Padova, Italy
                  address:
                     name:Department of Pediatrics, University of Padova, Via Giustiniani 3, I-35128 Padova, Italy, , IT
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Child's Nervous System
      issn:
         1433-0350
         0256-7040
      volumeNumber:15
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Departments of Oncology and Pediatrics, McGill University, 1650 Cedar Avenue, Room D5-400, Montreal, Quebec, Canada, H3G 1A4 e-mail: [email protected] Tel.: +1-514-934-8040 Fax: +1-514-934-8220
      address:
         name:Departments of Oncology and Pediatrics, McGill University, 1650 Cedar Avenue, Room D5-400, Montreal, Quebec, Canada, H3G 1A4 e-mail: [email protected] Tel.: +1-514-934-8040 Fax: +1-514-934-8220, , CA
         type:PostalAddress
      name:Department of Pediatrics, University of Padova, Via Giustiniani 3, I-35128 Padova, Italy
      address:
         name:Department of Pediatrics, University of Padova, Via Giustiniani 3, I-35128 Padova, Italy, , IT
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:C. R. Freeman
      affiliation:
            name:Departments of Oncology and Pediatrics, McGill University, 1650 Cedar Avenue, Room D5-400, Montreal, Quebec, Canada, H3G 1A4 e-mail: [email protected] Tel.: +1-514-934-8040 Fax: +1-514-934-8220
            address:
               name:Departments of Oncology and Pediatrics, McGill University, 1650 Cedar Avenue, Room D5-400, Montreal, Quebec, Canada, H3G 1A4 e-mail: [email protected] Tel.: +1-514-934-8040 Fax: +1-514-934-8220, , CA
               type:PostalAddress
            type:Organization
      name:Georgio Perilongo
      affiliation:
            name:Department of Pediatrics, University of Padova, Via Giustiniani 3, I-35128 Padova, Italy
            address:
               name:Department of Pediatrics, University of Padova, Via Giustiniani 3, I-35128 Padova, Italy, , IT
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Departments of Oncology and Pediatrics, McGill University, 1650 Cedar Avenue, Room D5-400, Montreal, Quebec, Canada, H3G 1A4 e-mail: [email protected] Tel.: +1-514-934-8040 Fax: +1-514-934-8220, , CA
      name:Department of Pediatrics, University of Padova, Via Giustiniani 3, I-35128 Padova, Italy, , IT
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(27)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.05s.

LINK . SPRINGER . COM {}